Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...
Korea JoongAng Daily on MSN27m
Six million Koreans have sleep apnea — and 80% of them don't know
F rom left, Park Do-hyun, head of Philips Korea's sleep and respiratory care division; Shehaan Fernando, head of Philips’ ...